Guardian Pharmacy Services (GRDN) Invested Capital (2023 - 2026)

Guardian Pharmacy Services (GRDN) has 4 years of Invested Capital data on file, last reported at $232.4 million in Q1 2026.

• Quarterly Invested Capital rose 42.4% year-over-year to $232.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $232.4 million (up 42.4% YoY) and the FY2025 annual result came in at $217.9 million, up 45.31% from the prior year.
• Invested Capital advanced to $232.4 million in Q1 2026 per GRDN's latest filing, from $217.9 million in the prior quarter.
• The five-year high for Invested Capital was $232.4 million in Q1 2026, with the low at $56.6 million in Q1 2024.
• Average Invested Capital over 4 years is $138.6 million, with a median of $150.0 million recorded in 2024.
• The widest YoY moves for Invested Capital: up 214.04% in 2025, down 35.86% in 2025.
• Guardian Pharmacy Services' Invested Capital stood at $68.9 million in 2023, then surged by 117.8% to $150.0 million in 2024, then soared by 45.31% to $217.9 million in 2025, then rose by 6.65% to $232.4 million in 2026.
• Business Quant data shows GRDN's Invested Capital at $232.4 million in Q1 2026, $217.9 million in Q4 2025, and $195.5 million in Q3 2025.